Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Boehringer Ingelheim
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Arcus Biosciences, Inc.
Eli Lilly and Company
Pfizer
AstraZeneca
M.D. Anderson Cancer Center
Regeneron Pharmaceuticals
Big Ten Cancer Research Consortium
Inhibrx Biosciences, Inc
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
Fundación GECP
Massachusetts General Hospital